Drug Shortage Report for MOMETASONE
| Report ID | 200446 |
| Drug Identification Number | 02519127 |
| Brand name | MOMETASONE |
| Common or Proper name | MOMETASONE |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 50MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL |
| Packaging size | 140 |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-31 |
| Estimated end date | |
| Actual end date | 2023-08-18 |
| Shortage status | Resolved |
| Updated date | 2023-08-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-08-29 | French | Compare |
| v4 | 2023-08-29 | English | Compare |
| v3 | 2023-08-01 | English | Compare |
| v2 | 2023-07-31 | French | Compare |
| v1 | 2023-07-31 | English | Compare |
Showing 1 to 5 of 5